Estatísticas para RT 2105 2020 - AFLIBERCEPTE (EYLLA), BEVACIZUMABE (AVASTIN). LUCENTIS - edema macular diabético - NATJUS TJMG

Total de visitas

views
RT 2105 2020 - AFLIBERCEPTE (EYLLA), BEVACIZUMABE (AVASTIN). LUCENTIS - edema macular diabético - NATJUS TJMG 2

Total visitas por mês

views
October 2025 0
November 2025 1
December 2025 0
January 2026 0
February 2026 0
March 2026 0
April 2026 1

Visitas Arquivos

views
RT 2020.0002105 - Aflibercepte.pdf 14